[
    [
        {
            "time": "",
            "original_text": "明星基金经理“减持”引市场“跟风”？生物疫苗龙头康泰生物连日大震荡 减持股份",
            "features": {
                "keywords": [
                    "明星基金经理",
                    "减持",
                    "康泰生物",
                    "市场跟风",
                    "大震荡"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "明星基金经理“减持”引市场“跟风”？生物疫苗龙头康泰生物连日大震荡 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【预见】股东拟减持，康华生物（300841.SZ）如何应对“成长的烦恼”？ 拟减持股份",
            "features": {
                "keywords": [
                    "股东减持",
                    "康华生物",
                    "成长烦恼"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【预见】股东拟减持，康华生物（300841.SZ）如何应对“成长的烦恼”？ 拟减持股份",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：原股东的优先认购通过深交所系统进行，并按要求进行认购委托",
            "features": {
                "keywords": [
                    "康泰生物",
                    "优先认购",
                    "深交所"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：原股东的优先认购通过深交所系统进行，并按要求进行认购委托",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：新型冠状病毒灭活疫苗（Vero细胞）已经在國內纳入紧急使用，目前己进入广东省、江苏省、四川省、贵州省、湖北省、湖南省、河南省等",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠疫苗",
                    "紧急使用",
                    "多省纳入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：新型冠状病毒灭活疫苗（Vero细胞）已经在國內纳入紧急使用，目前己进入广东省、江苏省、四川省、贵州省、湖北省、湖南省、河南省等",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：新冠灭活疫苗III期临床试验第一针接种预计2个月后获中期揭盲数据",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠疫苗",
                    "III期临床",
                    "中期数据"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：新冠灭活疫苗III期临床试验第一针接种预计2个月后获中期揭盲数据",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：截至2021年6月30日，公司共获得授权专利50项，包括肺炎类疫苗的专利",
            "features": {
                "keywords": [
                    "康泰生物",
                    "授权专利",
                    "肺炎疫苗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：截至2021年6月30日，公司共获得授权专利50项，包括肺炎类疫苗的专利",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：冻干人用狂犬病疫苗（人二倍体细胞）已按照新的《药品注册管理办法》申请药品注册批件",
            "features": {
                "keywords": [
                    "康泰生物",
                    "狂犬病疫苗",
                    "药品注册"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：冻干人用狂犬病疫苗（人二倍体细胞）已按照新的《药品注册管理办法》申请药品注册批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：公司半年度报告当前预约披露的时间为2021年8月30日",
            "features": {
                "keywords": [
                    "康泰生物",
                    "半年度报告",
                    "披露时间"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：公司半年度报告当前预约披露的时间为2021年8月30日",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：三胎支持政策出台 相关配套板块迎来机遇",
            "features": {
                "keywords": [
                    "医药生物",
                    "三胎政策",
                    "配套板块",
                    "机遇"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：三胎支持政策出台 相关配套板块迎来机遇",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "13股中报估值大幅下降+股价上涨空间超30%",
            "features": {
                "keywords": [
                    "中报估值",
                    "股价上涨",
                    "空间超30%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "13股中报估值大幅下降+股价上涨空间超30%",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "北向资金动向盘点：重手净买金融，大额净卖医药",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买金融",
                    "净卖医药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金动向盘点：重手净买金融，大额净卖医药",
                "Correlation": 4,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]